The triple transgenic (3xTg-AD: APP/PS1/tau) mouse demonstrates increased microglial density in the EC at 6 months, CA1 subfield at 12 months, and DG at 18 months, mimicking the regional and temporal distribution of pathology observed in AD brains [225,226,227]. Here, APP is linked to Alzheimer disease.